Table 1.
Author | Year | Country (Region) | Groups | n Included | n Completed | Studied Population | Obesity/Overweight Definition |
Age [Years] | Sex [% of Women] |
---|---|---|---|---|---|---|---|---|---|
Jamka et al. [38] | 2021 | Poland (Europe) | ET CT |
52 49 |
44 41 |
Abdominally obese women | BMI ≥ 30 kg/m2 WC > 80 cm %FM ≥ 32% |
55 ± 7 1 55 ± 7 1 |
100 |
Banitalebi et al. [39] Banitalebi et al. [40,75] |
2021 2019 |
Iran (Asia) | ET | 17 | 14 | Overweight or obese women with T2DM | BMI: 25–48 kg/m2 | 55.36 ± 5.94 1 | 100 |
CT | 17 | 14 | 54.14 ± 5.43 1 | ||||||
CG | 18 | 14 | 55.71 ± 6.40 1 | ||||||
Amanat et al. a [41] | 2020 | Iran (Asia) | ET | 15 | 14 | Overweight or obese women with metabolic syndrome | WC > 88 cm | 54.5 ± 6.9 1 | 100 |
ST | 15 | 14 | |||||||
CT | 15 | 15 | |||||||
CG | 15 | 14 | |||||||
Dianatinasab et al. a [42] | 2020 | Iran (Asia) | ET | 15 | 13 | Overweight or obese women with metabolic syndrome | WC > 88 cm | 53.47 ± 6.53 1 | 100 |
ST | 15 | 13 | |||||||
CT | 15 | 13 | |||||||
CG | 15 | 15 | |||||||
Dupuit et al. [37] | 2020 | France (Europe) | ET 2 | 10 | 8 | Overweight or obese postmenopausal women | BMI > 25 and ≤40 kg/m2 | 67.1 ± 7.2 1 | 100 |
ET 3 | 10 | 10 | 59.9 ± 5.9 1 | ||||||
CT | 10 | 9 | 61.1 ± 5.4 1 | ||||||
Kim et al. [43] | 2020 | South Korea (Asia) | ET | 19 | 13 | Previously inactive men with obesity | BMI ≥ 25 kg/m2 | 50.15 ± 5.84 1 | 0 |
ST | 19 | 14 | 51.79 ± 8.22 1 | ||||||
Christensen et al. [44] | 2019 | Denmark (Europe) | ET | 16 | 14 | Inactive subjects with abdominal obesity | WHR ≥ 0.5 and/or | 39 ± 14 1 | 79 |
ST | 16 | 13 | WC ≥ 88 cm for women or | 38 ± 14 1 | 62 | ||||
CG | 18 | 12 | WC ≥ 102 cm for men | 47 ± 12 1 | 83 | ||||
Keihanian et al. [45] | 2019 | Iran (Asia) | ET | 39 | 11 | Obese men with T2DM | BMI > 30 kg/m2 | 52.4 ± 1.5 1 | 0 |
ST | 12 | 52.4 ± 1.8 1 | |||||||
CG | 11 | 53.0 ± 1.1 1 | |||||||
Mohammad Rahimi et al. [46] | 2019 | Iran (Asia) | ET | 10 | 10 | Sedentary obese men with metabolic syndrome | BMI: 30–40 kg/m2 | 44.8 ± 4.8 1 | 0 |
ST | 11 | 10 | 46.1 ± 5.1 1 | ||||||
CT | 12 | 10 | 44.9 ± 4.2 1 | ||||||
CG | 11 | 10 | 46.4 ± 5.1 1 | ||||||
Ratajczak et al. [47] | 2019 | Poland (Europe) | ET | 22 | 22 | Women with simple obesity | BMI ≥ 30 kg/m2 and WC > 80 cm and %FM ≥ 33% |
51 ± 8 1 | 100 |
CT | 22 | 17 | 49 ± 10 1 | ||||||
Martins et al. [48] | 2018 | Brazil (South America) |
ET | 14 | 8 | Overweight women with high risk for T2DM, not exercising for at least 6 months | BMI > 24.9 kg/m2 and %FM > 40% |
64.3 ± 6.7 1 | 100 |
CT | 14 | 8 | 65.0 ± 6.3 1 | ||||||
Roberson et al. [49] | 2018 | USA (North America) |
ET | 10 | 8 | Older subjects with multiple cardiometabolic syndromes or cardiovascular disease risk factors | WC ≥ 88 cm for women or WC ≥ 102 cm for men |
68 ± 3 4 | 73 (included) 79 (completed) |
ST | 10 | 9 | 72 ± 3 4 | ||||||
CG | 10 | 7 | 70 ± 3 4 | ||||||
Alvarez et al. [50] | 2017 | Chile (South America) |
ET | 20 | 18 | Sedentary overweight or obese insulin-resistant women | BMI: 25–35 kg/m2 | 38.0 ± 8.0 1,5 | 100 |
ST | 20 | 17 | 33.0 ± 7.0 1,5 | ||||||
AminiLari et al. [51] | 2017 | Iran (Asia) | ET | 15 | 12 | Overweight middle-aged women with T2DM | NI | 45–60 6,7 | 100 |
ST | 15 | 12 | |||||||
CT | 15 | 13 | |||||||
CG | 15 | 15 | |||||||
Arslan et al. [52] | 2017 | Turkey (Asia) | ET | 78 | 21 | Middle-aged overweight premenopausal sedentary women |
BMI > 25 kg/m2 | 39.0 ± 3.1 1 | 100 |
CT | 20 | 38.7 ± 2.7 1 | |||||||
CG | 23 | 38.9 ± 3.1 1 | |||||||
Oh et al. [53] | 2017 | Japan (Asia) | ET 3 | 21 | 20 | Obese sedentary men with non-alcoholic fatty liver disease and no exercise habits | %FM > 25% for men | 48.6 ± 1.8 4 | 0 |
ET 2 | 19 | 13 | 48.2 ± 2.3 4 | ||||||
ST | 20 | 19 | 51.2 ± 1.9 4 | ||||||
Said et al. [54] | 2017 | Tunisia (Africa) | ET | 16 | NI | Healthy overweight and obese women | BMI: 25–35 kg/m2 | 30.58 ± 3.8 1 | 100 |
CT | 16 | 29.66 ± 4.2 1 | |||||||
Soori et al. [55] | 2017 | Iran (Asia) | ET | 8 | NI | Postmenopausal sedentary obese women | BMI ≥ 30 kg/m2 | 45–60 6,7 | 100 |
ST | 8 | ||||||||
CT | 8 | ||||||||
CG | 8 | ||||||||
Wang [56] | 2017 | China (Asia) | ET | 12 | NI | Obese undergraduates | BMI ≥ 28 kg/m2 | NI | NI |
CT | 12 | ||||||||
CG | 12 | ||||||||
Chen et al. [57] | 2016 | Malaysia (Asia) | ET | 20 | 18 | Overweight and obese subjects | BMI: 25–40 kg/m2 | 36.8 ± 8.1 1 | 65 |
ST | 20 | 18 | 34.8 ± 10.6 1 | ||||||
CG | 20 | 18 | 32.4 ± 9.9 1 | ||||||
Rossi et al. [21] | 2016 | Brazil (South America) |
ET | 35 | 15 | Obese postmenopausal Women |
BMI > 25 kg/m2 | 60.5 6 ± 7.3 1 | 100 |
CT | 35 | 32 | 60.3 ± 6.1 1 | ||||||
CG | 34 | 18 | 62.6 ± 5.9 1 | ||||||
Tayebi et al. [58] | 2016 | Iran (Asia) | ET | 12 | 11 | Non-athlete men with obesity | %FM > 25% | 21.48 ± 1.46 1,6 | 0 |
ST | 12 | 9 | |||||||
CT | 12 | 12 | |||||||
AbouAssi et al. b [20] | 2015 | USA (North America) |
ET | 196 | 27 | Sedentary overweight or obese subjects with mild to moderate dyslipidaemia | BMI: 26–35 kg/m2 | 51.4 ± 10 1 | 52 |
ST | 38 | 51.1 ± 11 1 | 47 | ||||||
CT | 23 | 46.9 ± 11 1 | 57 | ||||||
Mahdirejei et al. [14] | 2015 | Iran (Asia) | ET | 9 | NI | Obese men with no exercise training history | NI | 21/4 ± 15/41 1,6 | 0 |
ST | 9 | ||||||||
CG | 8 | ||||||||
Huffman et al. b [59] | 2014 | USA (North America) |
ET 8 | 15 | 15 | Inactive overweight to mildly obese and dyslipidaemic subjects | BMI: 25–35 kg/m2 | 18–70 6,7 | 50 |
ET 9 | 20 | 20 | |||||||
ET 10 | 17 | 17 | |||||||
ST | 20 | 20 | |||||||
CT | 20 | 20 | |||||||
CG | 20 | 20 | |||||||
Nikseresht et al. [16] | 2014 | Iran (Asia) | ET | 12 | NI | Sedentary overweight or obese men with no regular exercise and with no history of any medical condition | BMI >25 kg/m2 | 39.6 ± 3.7 1 | 0 |
ST | 12 | 40.4 ± 5.2 1 | |||||||
CG | 10 | 38.9 ± 4.1 1 | |||||||
Sousa et al. [60] | 2014 | Portugal (Europe) | ET | 19 | 15 | Overweight older men | BMI ≥ 25 and <35 kg/m2 | 69.1 ± 5.0 1,6 65–75 6,7 |
0 |
CT | 20 | 16 | |||||||
CG | 20 | 17 | |||||||
Changela et al. [61] | 2013 | India (Asia) | ET | 10 | NI | Young obese sedentary women | BMI > 30 kg/m2 | 22.22 ± 1.98 1 | 100 |
ST | 10 | 22.67 ± 1.50 1 | |||||||
Donges et al. [62] | 2013 | Australia (Australia) | ET | 13 | 13 | Sedentary overweight middle-aged men | NI | 45.4 ± 1.7 4 | 0 |
ST | 13 | 13 | 51.7 ± 2.1 4 | ||||||
CT | 13 | 13 | 46.2 ± 1.4 4 | ||||||
CG | 8 | 8 | 49.5 ± 2.6 4 | ||||||
Kadoglou et al. [63] | 2013 | Greece (Europe) | ET | 25 | 21 | Overweight or obese subjects with T2DM | BMI ≥ 25 kg/m2 | 58.3 ± 5.4 1 | 71 |
ST | 25 | 23 | 56.1 ± 5.3 1 | 70 | |||||
CT | 25 | 22 | 57.9 ± 6.5 1 | 77 | |||||
CG | 25 | 24 | 57.9 ± 7.2 1 | 71 | |||||
Paoli et al. [64] | 2013 | Italy (Europe) | ET | 21 | 20 | Healthy untrained overweight middle-aged men | BMI > 25 kg/m2 | 61 ± 3.3 1,6 | 0 |
CT 11 | 20 | 19 | |||||||
CT 12 | 19 | 19 | |||||||
Venojärvi et al. [65] | 2013 | Finland (Europe) | ET | 48 | 39 | Overweight and obese middle-aged men with impaired glucose tolerance | BMI: 25.1–34.9 kg/m2 | 55 ± 6.2 1 | 0 |
ST | 49 | 36 | 54 ± 6.1 1 | ||||||
CG | 47 | 40 | 54 ± 7.2 1 | ||||||
Ho et al. [66] | 2012 | Australia (Australia) | ET | 25 | 15 | Overweight or obese men and women, sedentary or relatively inactive, participating in less than 1 h of moderate-intensity physical activity per week over the last 3 months |
BMI >25 kg/m2 or WC > 80 cm for women and WC > 90 cm for men |
55 ± 1.2 13 | 80 |
ST | 26 | 16 | 52 ± 1.1 13 | 81 | |||||
CT | 25 | 17 | 53 ± 1.3 13 | 82 | |||||
CG | 21 | 16 | 52 ± 1.8 13 | 94 | |||||
Stensvold et al. c [67] | 2012 | Norway (Europe) | ET | 11 | 11 | Inactive subjects with metabolic syndrome | BMI ≥ 30 kg/m2 or WC ≥ 80 cm for women or WC ≥ 94 cm for men |
49.9 ± 10.1 1 | 23 |
ST | 11 | 10 | 50.9 ± 7.6 1 | ||||||
CG | 11 | 10 | 47.3 ± 10.2 1 | ||||||
Sukala et al. [68] | 2012 | New Zealand (Australia) | ET | 13 | 9 | Subjects with T2DM and visceral obesity | WC ≥ 88 cm for women or WC ≥ 102 cm for men |
51 ± 4 1 48 ± 6 1 |
72 |
ST | 13 | 9 | |||||||
Bateman et al. b [13] | 2011 | USA (North America) |
ET | 73 | 30 | Sedentary overweight dyslipidaemic subjects | BMI: 25–35 kg/m2 | 51.1 ± 9.49 1 | 47 |
ST | 66 | 31 | 51.8 ± 11.0 1 | 48 | |||||
CT | 57 | 25 | 45.8 ± 11.8 1 | 48 | |||||
Jorge et al. [69] | 2011 | Brazil (South America) |
ET | 12 | NI 14 | Overweight or obese subjects with T2DM | BMI: 25–40 kg/m2 | 52.09 ± 8.71 1 | 58 |
ST | 12 | 54.1 ± 8.94 1 | 58 | ||||||
CT | 12 | 57.90 ± 8.06 1 | 67 | ||||||
CG | 12 | 53.42 ± 9.82 1 | 67 | ||||||
Slentz et al. b [15] | 2011 | USA (North America) |
ET | 196 | 48 | Sedentary overweight dyslipidaemic subjects | BMI: 26–35 kg/m2 | 49.5 ± 9.8 1 | 54 |
ST | 52 | 49.7 ± 11.4 1 | 58 | ||||||
CT | 44 | 46.9 ± 10.0 1 | 57 | ||||||
Gram et al. [70] | 2010 | Denmark (Europe) | ET | 22 | 21 | Overweight or obese subjects with T2DM | BMI > 25 kg/m2 | 62 ± 10 1 | 54 |
CT | 24 | 24 | 59 ± 10 1 | 42 | |||||
CG | 22 | 22 15/20 16 | 61 ± 10 1 | 41 | |||||
Stensvold et al. c [22] | 2010 | Norway (Europe) | ET | 11 | NI | Subjects with metabolic syndrome | BMI ≥ 30 kg/m2 or WC ≥ 80 cm for women or WC ≥ 94 cm for men |
49.9 ± 10.1 1 | 40 |
ST | 11 | 50.9 ± 7.6 1 | |||||||
CT | 10 | 52.9 ± 10.4 1 | |||||||
CG | 11 | 47.3 ± 10.2 1 | |||||||
Ahmadizad et al. [71] | 2007 | Iran (Asia) | ET | 8 | NI | Sedentary obese healthy men | NI | 41.3 ± 5.1 1 | 0 |
ST | 8 | 40.9 ± 3.2 1 | |||||||
CG | 8 | 38.6 ± 3.2 1 | |||||||
Hara et al. [72] | 2005 | Japan (Asia) | ET | 7 | 7 | Young obese men | BMI > 25 kg/m2 | 19.7 ± 1.3 1 | 0 |
CT | 7 | 7 | 18.4 ± 0.5 1 | ||||||
CG | 7 | 7 | 19.4 ± 1.0 1 | ||||||
Banz et al. [73] | 2003 | USA (North America) |
ET | 14 | 11 | Men with android obesity and at least one risk factor for coronary artery disease | BMI > 27 kg/m2 and WHR > 0.95 |
47 ± 7 1 | 0 |
ST | 12 | 8 | 48 ± 6 1 | ||||||
Cuff et al. [74] | 2003 | Canada (North America) |
ET | 9 | 9 | Postmenopausal women with T2DM, central obesity and an inactive lifestyle | WC > 90 cm | 59.4 ± 1.9 4 | 100 |
CT | 10 | 10 | 63.4 ± 2.2 4 | ||||||
CG | 9 | 9 | 60.0 ± 2.9 4 |
BMI—body mass index; CG—control group; CT—combined training; ET—endurance training; NI—no information; ST—strength training; T2DM—type 2 diabetes mellitus; WC—waist circumference; WHR—waist to hip ratio; %FM—the percentage of fat mass. 1 Mean ± standard deviation; 2 Moderate-intensity continuous training; 3 High-intensity interval training; 4 Mean ± standard error; 5 34 ± 6 according to Table 2; 6 Data for the total population; 7 Range; 8 Low-amount moderate-intensity training group; 9 Low-amount vigorous-intensity training group; 10 High-amount vigorous-intensity training group; 11 High-intensity circuit training; 12 Low-intensity circuit training; 13 Mean ± standard error of means; 14 Five subjects dropped out (no information from which groups); 15 Data after 16 weeks; 16 Data after 52 weeks; a–c Studies marked with the same letters were conducted in the same population.